KUALA LUMPUR: A group of more than 50 health-related organisations and individuals is urging American biopharmaceutical company Gilead Sciences to allow Malaysia to import generic versions of remdesivir, an anti-viral drug used to treat Covid-19 patients.
The generic versions of remdesivir, which was originally developed to treat Ebola, are from manufacturers Gilead has given voluntary licensing (VL) agreements to.
Already a subscriber? Log in
Get 20% OFF The Star Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
